Forest Laboratories Inc. v. Glenmark Generics Inc. USA
1:14-cv-00159
Overview
Parties
Defendant
Glenmark Pharmaceuticals Ltd. Operating Company
Represented By
4 Attorneys ListedWhiteford, Taylor & Preston LLC
Whiteford, Taylor & Preston LLC, 600 N. King Street
Duane Morris LLP
1201 North Market Street, Suite 501
Faegre Drinker Biddle & Reath LLP
One Logan Square, Suite 2000
Eckert Seamans Cherin & Mellott, LLC
Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor
Glenmark Generics Ltd. Operating Company
Represented By
4 Attorneys ListedWhiteford, Taylor & Preston LLC
Whiteford, Taylor & Preston LLC, 600 N. King Street
Duane Morris LLP
1201 North Market Street, Suite 501
Faegre Drinker Biddle & Reath LLP
One Logan Square, Suite 2000
Eckert Seamans Cherin & Mellott, LLC
Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor
Glenmark Generics Inc. USA Operating Company
Represented By
6 Attorneys ListedWhiteford, Taylor & Preston LLC
Whiteford, Taylor & Preston LLC, 600 N. King Street
Duane Morris LLP
1201 North Market Street, Suite 501
Faegre Drinker Biddle & Reath LLP
One Logan Square, Suite 2000
Eckert Seamans Cherin & Mellott, LLC
Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor
Plaintiff
Royalty Pharma Collection Trust Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Forest Laboratories Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6602911
Methods of treating fibromyalgia
|
Filed: 2001-12-19
Issued: 2003-08-05
|
Expired (Term Ended)
+391d PTA
Expires: 2023-01-14
|
|
|
US7888342
Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain
|
Filed: 2009-12-22
Issued: 2011-02-15
|
Active (3.1 yrs remaining)
Expires: 2029-12-22
|
|
|
US7994220
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
Filed: 2006-09-26
Issued: 2011-08-09
|
Active (2.8 yrs remaining)
+1089d PTA
Expires: 2029-09-19
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+391 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
3
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings